PL367987A1 - Solid pharmaceutical formulation for a piperazine urea derivative - Google Patents

Solid pharmaceutical formulation for a piperazine urea derivative

Info

Publication number: PL367987A1
Authority: PL; Poland
Prior art keywords: pharmaceutical formulation; solid pharmaceutical; urea derivative; piperazine urea; piperazine
Prior art date: 2001-10-18

Application number

PL02367987A

Other languages

Polish (pl)

Inventor

Heiko Kranz

Christoph Völkel

Ralph Lipp

Johannes Tack

Herbert Wiesinger

Original Assignee

Schering Aktiengesellschaft

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2002-10-07

Publication date

2005-03-21

2002-10-07 Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft

2005-03-21 Publication of PL367987A1 publication Critical patent/PL367987A1/en

Links

239000008194 pharmaceutical composition Substances 0.000 title 1
QHTPSODXPLCXJB-UHFFFAOYSA-N piperazine;urea Chemical class NC(N)=O.C1CNCCN1 QHTPSODXPLCXJB-UHFFFAOYSA-N 0.000 title 1
239000007787 solid Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pulmonology (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL02367987A 2001-10-18 2002-10-07 Solid pharmaceutical formulation for a piperazine urea derivative PL367987A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10152351A DE10152351B4 (en)	2001-10-18	2001-10-18	Solid drug formulation for a piperazine urea derivative
PCT/EP2002/011229 WO2003035037A1 (en)	2001-10-18	2002-10-07	Solid pharmaceutical formulation for a piperazine urea derivative

Publications (1)

Publication Number	Publication Date
PL367987A1 true PL367987A1 (en)	2005-03-21

Family

ID=7703496

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL02367987A PL367987A1 (en)	2001-10-18	2002-10-07	Solid pharmaceutical formulation for a piperazine urea derivative

Country Status (23)

Country	Link
EP (1)	EP1435917A1 (en)
JP (1)	JP2005506365A (en)
KR (1)	KR20040047920A (en)
CN (1)	CN1571660A (en)
AR (1)	AR037111A1 (en)
AU (1)	AU2002333896B2 (en)
BR (1)	BR0213340A (en)
CA (1)	CA2463951A1 (en)
CO (1)	CO5580740A2 (en)
DE (1)	DE10152351B4 (en)
EC (1)	ECSP045108A (en)
HR (1)	HRP20040435A2 (en)
IL (1)	IL161166A0 (en)
MX (1)	MXPA04003522A (en)
NO (1)	NO20042022L (en)
NZ (1)	NZ532287A (en)
PE (1)	PE20030472A1 (en)
PL (1)	PL367987A1 (en)
RS (1)	RS32204A (en)
RU (1)	RU2311172C2 (en)
UY (1)	UY27500A1 (en)
WO (1)	WO2003035037A1 (en)
ZA (1)	ZA200403781B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2296979T3 (en)	2001-06-27	2008-05-01	Smithkline Beecham Corporation	FLUOROPIRROLIDINS AS INHIBITORS OF DIPEPTIDIL PEPTIDASA.
EP1749519A1 (en)	2005-08-05	2007-02-07	Schering Aktiengesellschaft	Dosage form with pH-independent sustained release for active substances with pH-dependent solubility
NZ703464A (en) *	2006-04-26	2016-05-27	Alphapharm Pty Ltd	Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
DE102008047910A1 (en)	2008-09-19	2010-03-25	Molkerei Meggle Wasserburg Gmbh & Co. Kg	Tabletting excipient based on lactose and cellulose
KR101654582B1 (en)	2016-05-12	2016-09-06	그린로드(주)	Conical Shaped Buoyant Polymer Filter and Apparatus for Manufacturing the same and Method for Manufacturing the same and Water Treatment Filter including the same
RU2729223C1 (en) *	2020-05-13	2020-08-05	Мераб Георгиевич Чикобава	Dosage form for amplification of nucleic acids

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1246383B (en) *	1990-04-17	1994-11-18	Eurand Int	METHOD FOR MASKING THE TASTE OF DRUGS
FR2668945B1 (en) *	1990-11-12	1993-02-19	Theramex	NEW PROCESS FOR THE CRYSTALLIZATION OF ORGANIC SUBSTANCES AND THE COMPOUNDS THUS OBTAINED.
US5705190A (en) *	1995-12-19	1998-01-06	Abbott Laboratories	Controlled release formulation for poorly soluble basic drugs
US6004996A (en) *	1997-02-05	1999-12-21	Hoffman-La Roche Inc.	Tetrahydrolipstatin containing compositions
US6207665B1 (en) *	1997-06-12	2001-03-27	Schering Aktiengesellschaft	Piperazine derivatives and their use as anti-inflammatory agents
NZ505724A (en) *	1998-02-05	2003-02-28	Pfizer Prod Inc	Dihydroxyhexanoic acid derivatives and their pharmaceutical use
ES2306646T3 (en) *	1999-02-09	2008-11-16	Pfizer Products Inc.	COMPOSITIONS OF BASIC PHARMACOS WITH INCREASED BIODISPONIBILITY.

2001
- 2001-10-18 DE DE10152351A patent/DE10152351B4/en not_active Expired - Fee Related
2002
- 2002-10-07 EP EP02801884A patent/EP1435917A1/en not_active Withdrawn
- 2002-10-07 MX MXPA04003522A patent/MXPA04003522A/en unknown
- 2002-10-07 AU AU2002333896A patent/AU2002333896B2/en not_active Ceased
- 2002-10-07 BR BR0213340-7A patent/BR0213340A/en not_active IP Right Cessation
- 2002-10-07 IL IL16116602A patent/IL161166A0/en unknown
- 2002-10-07 PL PL02367987A patent/PL367987A1/en not_active Application Discontinuation
- 2002-10-07 KR KR10-2004-7005591A patent/KR20040047920A/en not_active Ceased
- 2002-10-07 HR HR20040435A patent/HRP20040435A2/en not_active Application Discontinuation
- 2002-10-07 RU RU2004115328/15A patent/RU2311172C2/en not_active IP Right Cessation
- 2002-10-07 NZ NZ532287A patent/NZ532287A/en unknown
- 2002-10-07 CN CNA02820512XA patent/CN1571660A/en active Pending
- 2002-10-07 WO PCT/EP2002/011229 patent/WO2003035037A1/en not_active Ceased
- 2002-10-07 RS YU32204A patent/RS32204A/en unknown
- 2002-10-07 CA CA002463951A patent/CA2463951A1/en not_active Abandoned
- 2002-10-07 JP JP2003537604A patent/JP2005506365A/en active Pending
- 2002-10-17 PE PE2002001027A patent/PE20030472A1/en not_active Application Discontinuation
- 2002-10-17 UY UY27500A patent/UY27500A1/en not_active Application Discontinuation
- 2002-10-18 AR ARP020103929A patent/AR037111A1/en unknown
2004
- 2004-05-13 CO CO04044345A patent/CO5580740A2/en not_active Application Discontinuation
- 2004-05-14 NO NO20042022A patent/NO20042022L/en not_active Application Discontinuation
- 2004-05-17 ZA ZA200403781A patent/ZA200403781B/en unknown
- 2004-05-17 EC EC2004005108A patent/ECSP045108A/en unknown

Also Published As

Publication number	Publication date
ECSP045108A (en)	2004-06-28
KR20040047920A (en)	2004-06-05
DE10152351B4 (en)	2005-09-22
RS32204A (en)	2006-10-27
RU2311172C2 (en)	2007-11-27
PE20030472A1 (en)	2003-06-16
CN1571660A (en)	2005-01-26
EP1435917A1 (en)	2004-07-14
CO5580740A2 (en)	2005-11-30
ZA200403781B (en)	2004-11-29
CA2463951A1 (en)	2003-05-01
RU2004115328A (en)	2005-06-10
NO20042022L (en)	2004-05-14
AU2002333896B2 (en)	2007-07-26
AU2002333896A2 (en)	2003-05-06
UY27500A1 (en)	2003-06-30
IL161166A0 (en)	2004-08-31
NZ532287A (en)	2007-04-27
BR0213340A (en)	2004-10-05
WO2003035037A1 (en)	2003-05-01
AR037111A1 (en)	2004-10-20
HRP20040435A2 (en)	2005-06-30
JP2005506365A (en)	2005-03-03
MXPA04003522A (en)	2004-07-23
DE10152351A1 (en)	2003-05-08

Legal Events

Date	Code	Title	Description
2009-05-29	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
IL221199A (en)	2016-04-21	Pharmaceutical formulation comprising a scent
IL148357A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
PL364223A1 (en)	2004-12-13	Pharmaceutical salts
IL148406A0 (en)	2002-09-12	Pharmaceutical tramadol salts
HUP0302876A3 (en)	2005-05-30	Pharmaceutical formulation
GB0118689D0 (en)	2001-09-19	Pharmaceutical formulation
PL366432A1 (en)	2005-01-24	Pharmaceutical formulation
HUP0303948A2 (en)	2004-04-28	Solid orally-dispersible pharmaceutical formulation
GB0101225D0 (en)	2001-02-28	Pharmaceutical compounds
GB0031084D0 (en)	2001-01-31	Pharmaceutical compounds
IL148169A0 (en)	2002-09-12	Pharmaceutical compositions containing a benzamide derivative
IL161166A0 (en)	2004-08-31	Solid pharmaceutical formulation for a piperazine urea derivative
GB9914255D0 (en)	1999-08-18	Pharmaceutical compounds
AU2002333896A1 (en)	2003-07-03	Solid pharmaceutical formulation for a piperazine urea derivative
GB0019272D0 (en)	2000-09-27	Pharmaceutical compounds
GB2373499B (en)	2004-11-17	Pharmaceutical compounds
GB0024318D0 (en)	2000-11-15	Pharmaceutical compounds
HK1063285A (en)	2004-12-24	Solid pharmaceutical formulation for a piperazine urea derivative
AU2002342940A8 (en)	2003-06-10	New pharmaceutical compounds
GB0005366D0 (en)	2000-04-26	Pharmaceutical compounds
HRP20040757A2 (en)	2004-12-31	A stable pharmaceutical formulation comprising torsemide modification ii
GB0014849D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB0104749D0 (en)	2001-04-18	Pharmaceutical formulation
GB0014881D0 (en)	2000-08-09	Pharmaceutical aerosol formulation
GB0128335D0 (en)	2002-01-16	Pharmaceutical aerosol formulation